As of May 27
| +9.66 / +6.92%|
The 1 analysts offering 12-month price forecasts for Taro Pharmaceutical Industries Ltd have a median target of 205.00, with a high estimate of 205.00 and a low estimate of 205.00. The median estimate represents a +37.40% increase from the last price of 149.20.
The current consensus among 1 polled investment analysts is to Buy stock in Taro Pharmaceutical Industries Ltd. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.